Europe — EMA
Octanate Lv (Human Coagulation Factor Viii)
Human Coagulation Factor VIII, the active ingredient in Octanate Lv, is a blood coagulation factor presented as an intravenous solution for intravenous use.
Request sourcing
What is Human Coagulation Factor Viii?
Human Coagulation Factor VIII, the active ingredient in Octanate Lv, is a blood coagulation factor presented as an intravenous solution for intravenous use. It replaces deficient clotting factor in patients with hemophilia A. GNH USA supplies Octanate Lv as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
GNH USA supplies Octanate Lv as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
What is Human Coagulation Factor Viii used for?
Octanate Lv is used in the management of bleeding disorders that involve the intrinsic coagulation pathway, particularly hemophilia A.
- Hemophilia A (severe): Provides factor VIII replacement to control and prevent bleeding episodes. - Hemophilia A (moderate): Supports routine prophylaxis to reduce frequency of spontaneous bleeds. - Hemophilia A (mild): Used on‑demand to stop bleeding after injury or surgery. - Acquired hemophilia: Supplies the missing factor VIII to manage bleeding. - Surgical prophylaxis: Provides hemostatic coverage during invasive procedures in patients with factor VIII deficiency.
What are the side effects of Human Coagulation Factor Viii?
Octanate Lv may be associated with infusion‑related reactions and immunologic responses.
Common Side Effects: - Mild fever - Headache - Nausea - Injection site erythema - Transient increase in liver enzymes - Mild fatigue
Serious or Rare Side Effects: - Development of inhibitors (neutralizing antibodies) to factor VIII - Anaphylactic reactions - Severe hypersensitivity including rash or bronchospasm - Thromboembolic events - Renal impairment - Disseminated intravascular coagulation (DIA)
What precautions apply to Human Coagulation Factor Viii?
Octanate Lv should be administered under the supervision of a qualified healthcare professional experienced in hemophilia care.
- Monitoring: Regular assessment of factor VIII activity levels and inhibitor testing. - Allergic reactions: Observe for signs of hypersensitivity during and after infusion. - Surgery: Coordinate dosing with surgical teams to ensure adequate hemostasis. - Pregnancy: Use only if clearly needed; benefits must outweigh risks. - Pediatric use: Dosing and monitoring protocols differ from adults. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.
What does Human Coagulation Factor Viii interact with?
Octanutes
t t t """""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" """



